# HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

> **NCT01924351** · PHASE2 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Breast Cancer With Brain Metastasis

## Interventions

- **RADIATION:** Stereotactic Radiosurgery plus HER-2 directed therapy in HER2-positive Breast Cancer with Brain Metastasis

## Key facts

- **NCT ID:** NCT01924351
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924351, "HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01924351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*